These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3124591)

  • 1. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
    Slater W; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1988 Feb; 61(4):349-53. PubMed ID: 3124591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravation of ventricular arrhythmia. A drug-induced complication.
    Podrid PJ
    Drugs; 1985; 29 Suppl 4():33-44. PubMed ID: 3924550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T; Podrid PJ; Raeder E; Lown B
    Am J Cardiol; 1986 Aug; 58(5):87C-95C. PubMed ID: 3092625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
    Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM
    J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
    DiBianco R; Fletcher RD; Cohen AI; Gottdiener JS; Singh SN; Katz RJ; Bates HR; Sauerbrunn B
    Circulation; 1982 Jun; 65(6):1134-47. PubMed ID: 6804110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR; Manolis AS; Estes NA
    Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggravation of arrhythmia: a complication of antiarrhythmic drug therapy.
    Podrid PJ
    Eur Heart J; 1989 Sep; 10 Suppl E():66-72. PubMed ID: 2680505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encainide and flecainide: are they interchangeable?
    Saini V; Podrid PJ; Slater W; Lown B
    Am Heart J; 1989 Jun; 117(6):1253-8. PubMed ID: 2499169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ventricular tachyarrhythmias associated with the use of encainide.
    Winkle RA; Mason JW; Griffin JC; Ross D
    Am Heart J; 1981 Nov; 102(5):857-64. PubMed ID: 6795909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of antiarrhythmic response to encainide.
    Duff HJ; Roden DM; Carey EL; Wang T; Primm RK; Woosley RL
    Am J Cardiol; 1985 Nov; 56(13):887-91. PubMed ID: 3933319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
    Velebit V; Podrid P; Lown B; Cohen BH; Graboys TB
    Circulation; 1982 May; 65(5):886-94. PubMed ID: 6176355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L; Kadish A; Morady F
    Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased incidence of side effects after encainide: a newly developed antiarrhythmic drug.
    Berchtold-Kanz E; Schwarz G; Hust M; Nitsche K; Just H
    Clin Cardiol; 1984 Sep; 7(9):493-7. PubMed ID: 6442223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
    Poser RF; Podrid PJ; Lombardi F; Lown B
    Am Heart J; 1985 Jul; 110(1 Pt 1):9-16. PubMed ID: 4013993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ; Kessler KM; Cox MM; Huikuri H; Terracall E; Interian A; Fernandez P; Castellanos A
    Circulation; 1989 Dec; 80(6):1571-9. PubMed ID: 2480856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.